McGinley Orthopaedic Innovations appears in FDA’s 510(k) database as the applicant for K261189, the Freedom Nail Ankle Fusion System, with a decision date of October 19, 2026. The record describes a Traditional submission reviewed by the Orthopedic advisory committee under product code HSB and regulation number 888.3020, with a decision description of Substantially Equivalent. The company’s own product page lists the Freedom Nail as coming soon, alongside separate drill, plate and accessory products. The company describes itself as physician led, with a stated focus on patient safety and cost reduction in common medical procedures. [1][4][6][9]

The K261189 Filing and Its Scope

FDA’s record for K261189 identifies McGinley Orthopaedic Innovations as the applicant and the device as the Freedom Nail Ankle Fusion System. The submission is listed as Traditional, received April 10, 2026, and decided October 19, 2026, with decision code SESE and the description Substantially Equivalent. The product code is HSB, the regulation number is 888.3020, and the advisory committee is Orthopedic. The record notes a Summary statement and a third-party flag of N. [1][9]

The same filing is indexed in FDA’s 510(k) premarket notification database and in a third-party device record that repeats the applicant, product code, decision date and submission type. The linked classification references point to product code HSB and 21 CFR 888.3020. The filing address on the FDA record is in Casper, Wyoming; that address is a filing detail, not a verified headquarters designation. [2][9]

Published Product Line

McGinley Orthopedics’ product page lists IntelliSense Drill Technology, the Lever Action Plate System, IntelliSense Accessories, Revolver and Equalizer, and separately lists the Freedom Nail as coming soon. The site’s navigation names IntelliSense Drill Technology V2, the Lever Action Plate System, the Revolver Universal Drill Bit Guide and IntelliSense Accessories. The company states that its products are protected by U.S. patents, with additional patents pending. [4][6]

The company’s about page states that McGinley Orthopedics was established in April 2012 and identifies the IntelliSense Drill Technology as its flagship product, conceived by Dr. Joseph McGinley, Dr. Scott Kozin and Scott Porter. The same page quotes Adam Johnson, Director of Engineering, on patient safety as the focus of product development. These are company-published descriptions; no independent performance data appears in the numbered sources. [5]

Corporate and Regulatory Record

A Form 1-A filed with the SEC on August 11, 2022 identifies McGinley Orthopaedic Innovations, Inc. as a Wyoming corporation and lists Dr. Joseph McGinley as CEO, President, Treasurer and Secretary, signing in Casper, Wyoming. A Form 1-K annual report dated May 1, 2023 states that the Company filed to be a Wyoming corporation in 2022 under the name McGinley Orthopaedic Innovations, Inc. These filings describe the issuer; they do not establish a parent company or brand owner beyond the named entity. [7][8]

The FDA collection linked for this company contains one 510(k) record, K261189, with a decision count of one SESE. That count reflects the linked filings as of the snapshot date and is not a measure of total company sales, total portfolio or safety performance. No recall records appear in the linked sample. [1]

What the Record Does Not Establish

The numbered sources do not document commercial availability of the Freedom Nail Ankle Fusion System, clinical outcomes, customer relationships or certifications. The company site’s “coming soon” label for the Freedom Nail is a product-page status, not a regulatory determination. Claims about efficacy or patient selection are outside the scope of these records. [6][9]